A few months before Livongo and Teladoc Health inked a deal that valued Livongo at $18.5B, Jennifer Schneider, MD, MS, President of Livongo, took the stage at the StartUp Health Festival. Her telling of the company’s mission – to empower people with chronic conditions to live better and healthier lives – provides important context for the historic merger.
No transcript available.
POWERED BY BLUBRRY
